miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1

被引:78
|
作者
Fan, Song [1 ,2 ]
Chen, Wei-Xiong [2 ]
Lv, Xiao-Bin [3 ]
Tang, Qiong-Lan [4 ]
Sun, Li-Juan [5 ]
Liu, Bo-Du [5 ]
Zhong, Jiang-Long [2 ]
Lin, Zhao-Yu [2 ]
Wang, You-Yuan [2 ]
Li, Qun-Xing [2 ]
Yu, Xin [2 ]
Zhang, Han-Qing [2 ]
Li, Yi-Lin [6 ]
Wen, Bin [7 ]
Zhang, Zhang [8 ]
Chen, Wei-Liang [2 ]
Li, Jin-Song [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510120, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510120, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China
[6] Xaverian Bros High Sch, Westwood, MA 02090 USA
[7] Affiliated Hosp, North Sichuan Med Coll, Dept Pathol, Nanchang 637600, Peoples R China
[8] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Mitochondrial fission; Cisplatin sensitivity; miR-483-5p; FIS1; Tongue squamous cell carcinoma; DYNAMICS; RESISTANCE; APOPTOSIS; FLUOROURACIL; CHEMOTHERAPY; MECHANISMS; FUSION; TRIAL; HEAD; DRP1;
D O I
10.1016/j.canlet.2015.03.045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria play an important role in the initiation of apoptosis. However, whether cisplatin can induce apoptosis by initiating a mitochondrial fission pathway and the mechanism underlying this effect remain poorly understood. In this study, we show that the mitochondrial fission protein FIS1 is upregulated upon cisplatin treatment in tongue squamous cell carcinoma (TSCC) cells. FIS1 knockdown can attenuate mitochondrial fission and cisplatin sensitivity. We found that FIS1 is a direct target of miR-483-5p and that miR-483-5p can inhibit mitochondrial fission and cisplatin sensitivity in vitro and in vivo. Furthermore, we found that miR-483-5p and FIS1 are significantly associated with cisplatin sensitivity and with overall survival in patients with TSCC in a retrospective analysis of multiple centers. This study revealed that a novel mitochondrial fission pathway composed of miR-483-5p and FIS1 regulates cisplatin sensitivity. The modulation of miR-483-5p and FIS1 levels may provide a new approach for increasing cisplatin sensitivity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 50 条
  • [1] Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis
    Fan, Song
    Liu, Bodu
    Sun, Lijuan
    Lv, Xiao-Bin
    Lin, Zhaoyu
    Chen, Weixiong
    Chen, Weiliang
    Tang, Qionglan
    Wang, Youyuan
    Su, Yuxiong
    Jin, Shaowen
    Zhang, Daming
    Zhong, Jianglong
    Li, Yilin
    Wen, Bin
    Zhang, Zhang
    Yang, Pu
    Bin Zhou
    Liang, Qixiang
    Yu, Xing
    Zhu, Yinghua
    Hu, Pengnan
    Chu, Junjun
    Huang, Wei
    Feng, Yuhuan
    Peng, Hongzhuang
    Huang, Qihong
    Song, Erwei
    Li, Jinsong
    ONCOTARGET, 2015, 6 (17) : 14885 - 14904
  • [2] Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma
    Xue, Liying
    Nan, Jinglong
    Dong, Li
    Zhang, Cuiying
    Li, Hui
    Na, Rentuya
    He, Huijie
    Wang, Yadi
    CANCER BIOMARKERS, 2017, 19 (02) : 193 - 197
  • [3] miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1
    Tian, Yunhong
    Yan, Miaohong
    Zheng, Jielin
    Li, Rong
    Ling, Jie
    Xu, Anan
    Liang, Yingying
    Zheng, Ronghui
    Yuan, Yawei
    LABORATORY INVESTIGATION, 2019, 99 (05) : 602 - 611
  • [4] Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma
    Xu, Huanxi
    Yang, Yuqi
    Zhao, Hongmei
    Yang, Xuguang
    Luo, Yu
    Ren, Yinxiang
    Liu, Wei
    Li, Ning
    TUMOR BIOLOGY, 2016, 37 (01) : 447 - 453
  • [5] miR-483-5p promotes esophageal cancer progression by targeting KCNQ1
    Chen, Yong
    Wang, Hanying
    Zhu, Shuangmei
    Lan, Xiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (04) : 615 - 621
  • [6] miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5
    Yang, Zhi-Gang
    Ma, Xu-Dong
    He, Zhao-Hui
    Guo, Ying-xin
    INTERNATIONAL BRAZ J UROL, 2017, 43 (06): : 1060 - 1067
  • [7] MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma
    Wang, Xue-Gang
    Zhu, Yong-Wu
    Wang, Tao
    Chen, Bin
    Xing, Jin-Chun
    Xiao, Wen
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2021, 37 (03): : 192 - 199
  • [8] miR-590-5P inhibits the progression of tongue squamous cell carcinoma by targeting FasL
    Xu, Yanxue
    Han, Tongtong
    Zhu, Youming
    Chen, Qiaoer
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11880 - 11887
  • [9] miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM
    Song, Qiancheng
    Xu, Yuanfei
    Yang, Cuilan
    Chen, Zhenguo
    Jia, Chunhong
    Chen, Juan
    Zhang, Yue
    Lai, Pinglin
    Fan, Xiaorong
    Zhou, Xuan
    Lin, Jun
    Li, Ming
    Ma, Wenli
    Luo, Shenqiu
    Bai, Xiaochun
    CANCER RESEARCH, 2014, 74 (11) : 3031 - 3042
  • [10] MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1
    Wang, Li
    Shi, Ming
    Hou, Shuangxing
    Ding, Bojun
    Liu, Lijuan
    Ji, Xituan
    Zhang, Jian
    Deng, Yanchun
    FEBS LETTERS, 2012, 586 (09) : 1312 - 1317